Doxycycline Hyclate VMD 500 mg/g Powder for Use in Drinking Water for Chickens

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Doxycycline Hyclate

제공처:

VMD NV

ATC 코드:

QJ01AA02

INN (International Name):

Doxycycline Hyclate

약제 형태:

Powder for use in drinking water

처방전 유형:

POM-V - Prescription Only Medicine – Veterinarian

치료 그룹:

Chickens

치료 영역:

Antimicrobial

승인 상태:

Authorized

승인 날짜:

2011-11-29

제품 특성 요약

Revised: February 2018
AN: 01687/2017
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Doxycycline Hyclate VMD 500 mg/g Powder for Use in Drinking Water for
Chickens
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One gram contains:
ACTIVE SUBSTANCE:
Doxycycline hyclate 500 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder for use in drinking water
Homogeneous, fine, yellow powder.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Non-egg laying chickens.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of the following specified infections of the respiratory
tract and alimentary
tract caused by micro-organisms susceptible to doxycycline.
Non-egg laying chickens:
Infections of the respiratory tract caused by _Mycoplasma spp,
Escherichia coli,_
_Avibacterium paragallinarum_ and _Bordetella avium_.
Enteritis caused by _Clostridium perfringens _and_ Clostridium
colinum._
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to tetracyclines or any of the
excipients.
Do not administer to animals with severe liver or kidney
insufficiency.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Due to variability (time, geographical) in susceptibility of bacteria
to doxycycline,
bacteriological sampling and susceptibility testing of micro-organisms
from diseased
animals on farm are highly recommended.
A high resistance rate of _E.coli_ isolated from chickens, against
tetracyclines has been
documented. Therefore the product should be used for the treatment of
infections
caused by _E.coli_ only after susceptibility testing has been carried
out.
Revised: February 2018
AN: 01687/2017
Page 2 of 5
As eradication of the target pathogen may not be achieved, medication
should
therefore be combined with good management practices e.g. good
hygiene, proper
ventilation, no overstocking.
Special precautions to be taken by the person administering the
veterinary medicina